In 2026, the question for enterprise AI is no longer whether predictive models can outperform statistical forecasts—that argument is settled. The big question now is how to enable predictive systems to act on their own conclusions without drifting from business intent. The frontier has moved from prediction to autonomous decision making, and the gap between…
Elon Musk says a secretive new SpaceX foundry will let him cast his own turbine blades and get gas power online 18 months faster than anyone else — but it’s a bet on a fuel source that’s already triggering lawsuits and health studies everywhere his (and others’) turbines have gone in.
Investors, founders, and operators from across Europe arrived for the annual Nordic TechBBQ conference to talk about how humans can have agency over AI.
Vijay Pande — who left a16z’s roughly $4 billion biotech practice last year to start the much smaller, AI-native VZVC — talks about why biology is finally shifting from a “discovery” science to an “engineering” one, why clinical trials are still brutally expensive, and why he thinks open, shared datasets (not walled-off ones) are what will actually let AI transform medicine.